Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,095,372
-$34,429 QoQ
Shares Held
4,313
-6.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.14%
of 13F equity value
Holder Rank
#2,928
of 4,664 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CASTLEKEEP INVESTMENT ADVISORS LLC holds $2,159,814 across 2 Drug Manufacturers - General names. JNJ ranks #1 (50.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
4,313 | $1,095,372 | |
| 2 | NVS |
Novartis AG
|
6,792 | $1,064,442 |
All Filings in JNJ
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,095,372 | 4,313 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,129,801 | 4,622 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,053,582 | 5,091 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,015,545 | 5,477 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $1,168,537 | 7,650 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $1,346,454 | 8,119 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $1,134,833 | 7,847 | Shares | Sole | 2025-02-20 | |
| 2024-09-30 | $1,193,733 | 7,366 | Shares | Sole | 2025-02-21 | |
| 2024-06-30 | $978,248 | 6,693 | Shares | Sole | 2025-02-14 | |
| 2024-03-31 | $1,061,771 | 6,712 | Shares | Sole | 2025-02-14 | |
| 2023-12-31 | $2,906,743 | 18,545 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||